Rajesh Pahwa

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression”.

Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression

JAMA(2021)10.1001/jama.2021.10207

N/A

4.5DataRank · unranked

160 citations

Brent Bluett, Daniel M. Togasaki, Dragos Mihaila, Marian L. Evatt, Michael Rezak +95 more

Improved Sleep Correlates with Improved Quality of Life and Motor Symptoms with Foslevodopa/Foscarbidopa

Movement Disorders Clinical Practice(2024)10.1002/mdc3.14018

N/A

0.808DataRank · unranked

19 citations

Maurizio Facheris, Bruno Bergmans, Filip Bergquist, Susan R. Criswell, Jia Jia +7 more

Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson’s Disease and Dyskinesia

Neurology and Therapy(2021)10.1007/s40120-021-00246-3

N/A

0.663DataRank · unranked

17 citations

Rajesh Pahwa, Caroline M. Tanner, Robert A. Hauser, Reed Johnson, Shyamal H. Mehta

MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study

The Lancet Neurology(2024)10.1016/s1474-4422(24)00083-8

N/A

0.477DataRank · unranked

23 citations

William J. Scotton, Shanu F. Roemer, Tammaryn Lashley, Michael G. Heckman, Maryam Shoai +95 more

Feasibility of home dose optimization of apomorphine sublingual film in Parkinson’s disease patients with OFF episodes: results from the dose-optimization phase of an open-label, randomized crossover study

Therapeutic Advances in Neurological Disorders(2023)10.1177/17562864231209240

N/A

0DataRank · unranked

5 citations

Fabrizio Stocchi, Ernest Balaguer Martinez, Rajesh Pahwa, William G. Ondo, Yi Zhang +6 more

Dopaminergic Basis of Spatial Deficits in Early Parkinson’s Disease

Cerebral Cortex Communications(2021)10.1093/texcom/tgab042

N/A

0DataRank · unranked

2 citations

Rajesh Pahwa, Kelly E. Lyons, Brenda Hanna‐Pladdy

Pupillary Response to Postural Demand in Parkinson’s Disease

Frontiers in Bioengineering and Biotechnology(2021)10.3389/fbioe.2021.617028

N/A

0DataRank · unranked

15 citations

Kelly E. Lyons, Rajesh Pahwa, Abiodun Akinwuntan, Jianghua He, Hannes Devos +1 more

EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s Disease

Journal of Parkinson s Disease(2020)10.3233/jpd-191841

N/A

0DataRank · unranked

36 citations

Rajesh Pahwa, Robert A. Hauser, Wolfgang H. Oertel, Stuart Isaacson, Joseph Jankovic +4 more

How to manage the initiation of apomorphine therapy without antiemetic pretreatment: A review of the literature

Clinical Parkinsonism & Related Disorders(2022)10.1016/j.prdoa.2022.100174

N/A

0DataRank · unranked

10 citations

Richard B. Dewey, Rajesh Pahwa, Daniel Kremens, Stuart Isaacson